Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers.
Vidal L, Dlamini Z, Qian S, Rishi P, Karmo M, Joglekar N, Abedin S, Previs RA, Orbegoso C, Joshi C, Azim HA, Karkaria H, Harris M, Mehrotra R, Berraondo M, Werutsky G, Gupta S, Niikura N, Chico I, Saini KS. Vidal L, et al. Among authors: orbegoso c. ESMO Open. 2024 May;9(5):103373. doi: 10.1016/j.esmoop.2024.103373. Epub 2024 May 7. ESMO Open. 2024. PMID: 38718705 Free PMC article. Review.
Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
Flood E, Krasnow A, Orbegoso C, Karantzoulis S, Bailey J, Bayet S, Elghouayel A, Foxley A, Sommavilla R, Schiavon G. Flood E, et al. Among authors: orbegoso c. PLoS One. 2023 Jan 17;18(1):e0280259. doi: 10.1371/journal.pone.0280259. eCollection 2023. PLoS One. 2023. PMID: 36649275 Free PMC article.
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.
Saini KS, de Las Heras B, Plummer R, Moreno V, Romano M, de Castro J, Aftimos P, Fredriksson J, Bhattacharyya GS, Olivo MS, Schiavon G, Punie K, Garcia-Foncillas J, Rogata E, Pfeiffer R, Orbegoso C, Morrison K, Curigliano G, Chin L, Saini ML, Rekdal Ø, Anderson S, Cortes J, Leone M, Dancey J, Twelves C, Awada A. Saini KS, et al. Among authors: orbegoso c. JCO Glob Oncol. 2020 Sep;6:1357-1362. doi: 10.1200/GO.20.00346. JCO Glob Oncol. 2020. PMID: 32897732 Free PMC article. No abstract available.
The current status of immunotherapy for cervical cancer.
Orbegoso C, Murali K, Banerjee S. Orbegoso C, et al. Rep Pract Oncol Radiother. 2018 Nov-Dec;23(6):580-588. doi: 10.1016/j.rpor.2018.05.001. Epub 2018 May 18. Rep Pract Oncol Radiother. 2018. PMID: 30534022 Free PMC article. Review.
The role of Cediranib in ovarian cancer.
Orbegoso C, Marquina G, George A, Banerjee S. Orbegoso C, et al. Expert Opin Pharmacother. 2017 Oct;18(15):1637-1648. doi: 10.1080/14656566.2017.1383384. Expert Opin Pharmacother. 2017. PMID: 28933580 Review.
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Sebbagh S, Roux J, Dreyer C, Neuzillet C, de Gramont A, Orbegoso C, Hentic O, Hammel P, de Gramont A, Raymond E, André T, Chibaudel B, Faivre S. Sebbagh S, et al. Among authors: orbegoso c. Acta Oncol. 2016 Sep-Oct;55(9-10):1168-1174. doi: 10.1080/0284186X.2016.1191670. Epub 2016 Jun 22. Acta Oncol. 2016. PMID: 27333436
DVT Management and Outcome Trends, 2001 to 2014.
Morillo R, Jiménez D, Aibar MÁ, Mastroiacovo D, Wells PS, Sampériz Á, Saraiva de Sousa M, Muriel A, Yusen RD, Monreal M; RIETE investigators. Morillo R, et al. Chest. 2016 Aug;150(2):374-83. doi: 10.1016/j.chest.2016.03.046. Epub 2016 Apr 9. Chest. 2016. PMID: 27071810
22 results